Let’s accelerate your projects with our laboratory services
Our own laboratories are based in Europe (near Paris, France), making it simple for you to promptly initiate projects with us as soon as the need arises. We perform a broad range of services, which can easily be combined to facilitate handling of your project, with one provider. Whether you’re looking for ready-to-go or fully customized laboratory services, our expertise in multiple areas ensures our teams can define the best strategy with you, for your project.
2D culture: plating,
3D models & Co-culture:
hypoxia, shear stress...
MoA identification & validation
In-vitro toxicology screening
Target selectivity & efficiency
Project design & strategy definition
Small to Medium production scale
Multiple variant screening
Meet your team of scientists
You’ll enjoy easy dialogue and regular exchanges with your designated project manager, with confidentiality always guaranteed. Their own background and experience in research enable them to genuinely comprehend your needs.
We are always happy to invite our customers to visit our laboratories - our reputation is built on the mutual trust we nurture with them.
An example of the services our experts provide - custom mRNA production
Scientific solutions, but not only
When we build your project with you, we cover all that it requires - beyond the scientific aspects. We can arrange secure shipping of your samples from your lab to ours, or we can source the required reagents and samples for you.
Your Account Manager and your Project Manager will accompany you at all times to build the solution that meets your needs, and communicate with you throughout your project.
What’s the next project we can start together?
Discover some case studies
Browse some examples of the projects we have built with our customers and performed for them.
See the advantages our solutions brought to advance their research.
Evaluating the impact of key cell-culture parameter modulation on the predictivity for the identification of specific inhibitors and biomarkers on cancer models
Our customer needed to investigate whether modulating key culture parameters could improve the predictivity of their colorectal cancer cell-based methodology used to select CDK8 inhibitors and/or identify biomarkers.
We performed comparative analysis for them, which involved developing two HT-29 colorectal cancer models: as monolayers in a conventional incubator and as 3D spheroids under physioxia, in the presence/absence of gamma-interferon.
On each model, a viability assay was performed after 3 days incubation time with inhibitors, followed by large-scale proteome profiling analysis on 2000 targets from each cell lysates.
Development of cost effective and robust 3D Colorectal Cancer models for physiological drug response analysis
Our customer needed to obtain in-vivo like responses to drug treatment, through monitoring parameters such as gene expression, biomarker analysis, cellular viability, invasion capability.
We established and implemented a physiologically relevant 3D Colorectal cancer cell-based assay. To answer questions related to variations at transcription and protein level, our methodology required long-term imaging at controlled temperature and gas levels (CO2 and O2), on both 3D cellular models and patient-derived samples. Impact of an anti-cancerous drug was investigated on colon cell lines (HT-29, HCT116 and LS174T) in conventional 2D monolayer and 3D spheroid cultures, in hypoxia or normoxia. Methods used were metastatic invasion assay, gene expression analysis by RT-PCR on hypoxic response and oncopathway genes, and large-scale protein profiling to detect proteomic levels of metalloproteinases and surface proteins known to be involved in colorectal cancer invasion.
Screening of optimal conditions in order to obtain a difficult to produce protein in HEK 293 cells
Obtaining high yields of pure and active difficult-to-produce recombinant proteins can be a real challenge and may require significant investment. The rapid screening of multiple production and purification conditions on a small scale is fundamental to identify the optimal strategy.
To select the best production conditions in HEK 293 EBNA cells, we first performed a small volume expression study to define optimal production time and ratio of DNA/transfection reagent. Moreover, we tested addition to the cell culture medium of various supplements (amino acids, inorganic salts, lipids…), aiming at boosting the expression level by varying medium composition. On identification of the best production conditions, several buffer compositions were screened at purification level to improve stability and solubility of the protein of interest. Different buffers, detergents, sugars, as well as α-helix stabilizers, and many more, were tested in a 96-well format for high-throughput.
Production of eGFP mRNA labeled with fluorophore to assess its encapsulation efficiency in LNPs
We produced eGFP mRNA labeled with fluorophore, enabling our customers to assess its encapsulation efficiency in LNPs and monitor its delivery efficiency in mammalian cells.
Tebubio lab has developed a plasmid template for the mRNA production, optimized for efficient transcription and translation in mammalian cells. By using Andy Fluor-UTP (refs. C410, C412, C414, C416, C418), it is possible to obtain fluorescent mRNA detectable at green, orange and red wavelengths. As a proof of concept, we have produced eGFP mRNA modified with Andy Fluor 647-X-UTP, transfected it in HEK293 cells and detected the mRNA delivery in the cells as well as the eGFP expression by fluorescent microscopy.